Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases.
Ren GM, Li J, Zhang XC, Wang Y, Xiao Y, Zhang XY, Liu X, Zhang W, Ma WB, Zhang J, Li YT, Tao SS, Wang T, Liu K, Chen H, Zhan YQ, Yu M, Li CY, Ge CH, Tian BX, Dou GF, Yang XM, Yin RH.
Ren GM, et al. Among authors: li j, li cy, li yt.
Sci Immunol. 2021 Apr 30;6(58):eabe2933. doi: 10.1126/sciimmunol.abe2933.
Sci Immunol. 2021.
PMID: 33931568